April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Using a Self-Assembling Nanopeptide to Achieve Ocular Hemostasis Without Causing Clotting or Secondary Inflammation
Author Affiliations & Notes
  • R. G. Ellis-Behnke
    Anatomy-1/F, Lab Blck, University of Hong Kong, Pokfulam, Hong Kong
    Brain & Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts
  • Y. Liang
    Anatomy-1/F, Lab Blck, University of Hong Kong, Pokfulam, Hong Kong
  • S. W. H. Cheung
    Anatomy-1/F, Lab Blck, University of Hong Kong, Pokfulam, Hong Kong
  • K.-F. So
    Anatomy, The University of Hong Kong, Hong Kong, China
  • D. K. C. Tay
    Anatomy-1/F, Lab Blck, University of Hong Kong, Pokfulam, Hong Kong
  • Footnotes
    Commercial Relationships  R.G. Ellis-Behnke, Arch Therapeutics, I; Arch Therapeutics, C; Patent, P; Y. Liang, Patent, P; S.W.H. Cheung, None; K.-F. So, Patent, P; D.K.C. Tay, Patent, P.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 427. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      R. G. Ellis-Behnke, Y. Liang, S. W. H. Cheung, K.-F. So, D. K. C. Tay; Using a Self-Assembling Nanopeptide to Achieve Ocular Hemostasis Without Causing Clotting or Secondary Inflammation. Invest. Ophthalmol. Vis. Sci. 2010;51(13):427.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Hemostasis is a major problem in ocular surgical procedures. There are few effective methods to stop bleeding without causing secondary damage.

Methods: : We made a laceration to the the sclera, cornea, or limbal vein in hamsters and rats and then applied a self-assembling nanopeptide (SAP) to the wound. For intraocular procedures we were able to directly inject the material at the site of injury.

Results: : Complete hemostasis was achieved in less than 15 seconds when applied intraocularly, or directly to the surface of the sclera. The SAP stopped bleeding in less than 15 seconds and stabilized the local environment, without causing blockage of the vascular flow or an immune response. The novel therapy stops bleeding without the use of pressure, cauterization, vasoconstriction, coagulation, or cross-linked adhesives. The self-assembling solution is nontoxic and nonimmunogenic, and the breakdown products are amino acids, which are tissue building blocks that can be used to repair the site of injury.

Conclusions: : This is the first use of nanotechnology to achieve ocular hemostasis in less than 15 seconds, both internally and externally, without causing secondary inflammation.

Keywords: trauma • sclera • wound healing 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×